BSE filing, NSE: GODIGIT. Summary written from the filing by ALFA Finder's alert engine.
Go Digit General Insurance Ltd: key numbers
- Share price
- ₹252.90
- Market cap
- ₹23,324 Cr
- Revenue (annual)
- ₹10,005 Cr
- Net profit (annual)
- ₹544.4 Cr
- P/E (TTM)
- 45.2×Sector 19.1×
- Promoter holding
- 72.96%-0.04% QoQ
- FII holding
- 6.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Go Digit General Insurance Ltd
All →Go Digit General Insurance Board Meeting Date
Go Digit General Insurance has scheduled a board meeting on 5 November 2026 to approve unaudited Q2 and H1 FY27 results. The trading window stays closed until 9 November 2026.
Go Digit General Insurance Credit Rating
Go Digit General Insurance's CRISIL corporate credit rating was re-affirmed at AA- on 23 October 2026. The outlook moved from Rating Watch with Developing Implications to Rating Watch with Positive Implications.
Go Digit General Insurance Other Announcement
The company submitted its quarterly shareholding pattern report as required under SEBI regulations.
Go Digit General Insurance Merger & Restructuring
Fairfax announced a proposed acquisition of IDBI Bank and intends to contribute Go Digit to IDBI Bank. The proposal is currently conditional and subject to approvals.
Go Digit General Insurance Credit Rating
Cril re-affirmed Go Digit General Insurance Ltd's Corporate Credit Rating as AA-. The rating carries a Rating Watch with Developing Implications, flagging a potential future change.
Go Digit General Insurance Acquisition
Go Digit General Insurance updated its draft Scheme of Amalgamation with Go Digit Infoworks Services to include mandatory regulatory references required by the IRDAI.
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031